TY - JOUR
T1 - Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline
AU - Manes, Gianpiero
AU - Paspatis, Gregorios
AU - Aabakken, Lars
AU - Anderloni, Andrea
AU - Arvanitakis, Marianna
AU - Ah-Soune, Philippe
AU - Barthet, Marc
AU - Domagk, Dirk
AU - Dumonceau, Jean-Marc
AU - Gigot, Jean-Francois
AU - Hritz, Istvan
AU - Karamanolis, George
AU - Laghi, Andrea
AU - Mariani, Alberto
AU - Paraskeva, Konstantina
AU - Pohl, Jürgen
AU - Ponchon, Thierry
AU - Swahn, Fredrik
AU - Ter Steege, Rinze W. F.
AU - Tringali, Andrea
AU - Vezakis, Antonios
AU - Williams, Earl J.
AU - Van Hooft, Jeanin E.
PY - 2019
Y1 - 2019
N2 - Gallstones are a very common problem in developed countries
[1 – 3]. Most patients with gallstones remain asymptomatic
throughout their lifetime [4, 5], but 10%– 25% of them may develop
biliary pain or complications [6 – 9], with an annual risk of
about 2%– 3% for symptomatic disease [10] and 1%–2% for
major complications [11]. The development of symptomatic
disease and complications is mostly related to the migration of
stones into the common bile duct (CBD). Common bile duct
stones (CBDSs) may be treated by endoscopic retrograde
cholangiopancreatography (ERCP) or surgically during cholecystectomy.
The aim of this evidence- and consensus-based
Guideline, commissioned by the European Society of Gastrointestinal
Endoscopy (ESGE), is to provide practical advice on
how to manage patients with CBDSs. It considers diagnostic
strategies in patients with suspected CBDSs, as well as the different
therapeutic options available for CBDSs.
AB - Gallstones are a very common problem in developed countries
[1 – 3]. Most patients with gallstones remain asymptomatic
throughout their lifetime [4, 5], but 10%– 25% of them may develop
biliary pain or complications [6 – 9], with an annual risk of
about 2%– 3% for symptomatic disease [10] and 1%–2% for
major complications [11]. The development of symptomatic
disease and complications is mostly related to the migration of
stones into the common bile duct (CBD). Common bile duct
stones (CBDSs) may be treated by endoscopic retrograde
cholangiopancreatography (ERCP) or surgically during cholecystectomy.
The aim of this evidence- and consensus-based
Guideline, commissioned by the European Society of Gastrointestinal
Endoscopy (ESGE), is to provide practical advice on
how to manage patients with CBDSs. It considers diagnostic
strategies in patients with suspected CBDSs, as well as the different
therapeutic options available for CBDSs.
KW - Bile duct stones
KW - Bile duct stones
UR - http://hdl.handle.net/10807/134870
UR - http://www.thieme-connect.com/ejournals/toc/endoscopy
U2 - 10.1055/a-0862-0346
DO - 10.1055/a-0862-0346
M3 - Article
SN - 0013-726X
VL - 51
SP - 472
EP - 491
JO - Endoscopy
JF - Endoscopy
ER -